Sign up to save your podcasts
Or
Share ATTR-CM Under Siege ⚔️ Vutrisiran's Defense 🛡️ Victory for the Heart 🏆
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ATTR-CM Under Siege ⚔️ Vutrisiran's Defense 🛡️ Victory for the Heart 🏆
🚨 New Insights from HELIOS-B 🫀✨
In patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the RNA interference therapy vutrisiran not only reduced mortality and cardiovascular events, but also showed measurable benefits in cardiac structure and function over 30 months.
📉 Thinner LV walls & lower LV mass index
💪 Preserved ejection fraction & stroke volume
⚙️ Improved diastolic function – better E/e′ & e′ velocity
🏆 Benefits seen even with substantial tafamidis use
These findings support early initiation of vutrisiran to protect the heart and slow disease progression.
#Cardiology #HeartFailure #ATTRCM #RNAi #Vutrisiran #HELIOSB #Echocardiography #HeartHealth ❤️
View all episodes
By Dr RR Baliga, MD, MBA
5
66 ratings
🚨 New Insights from HELIOS-B 🫀✨
In patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the RNA interference therapy vutrisiran not only reduced mortality and cardiovascular events, but also showed measurable benefits in cardiac structure and function over 30 months.
📉 Thinner LV walls & lower LV mass index
💪 Preserved ejection fraction & stroke volume
⚙️ Improved diastolic function – better E/e′ & e′ velocity
🏆 Benefits seen even with substantial tafamidis use
These findings support early initiation of vutrisiran to protect the heart and slow disease progression.
#Cardiology #HeartFailure #ATTRCM #RNAi #Vutrisiran #HELIOSB #Echocardiography #HeartHealth ❤️
More shows like Dr RR Baliga's "Got Knowledge Doc" Podkast
View all
This Week in Cardiology
907 Listeners
The Curbsiders Internal Medicine Podcast
3,375 Listeners
The Mel Robbins Podcast
20,649 Listeners